Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports.

Kehl KL, Elmarakeby H, Nishino M, Van Allen EM, Lepisto EM, Hassett MJ, Johnson BE, Schrag D.

JAMA Oncol. 2019 Jul 25. doi: 10.1001/jamaoncol.2019.1800. [Epub ahead of print]

PMID:
31343664
2.

The influence of nutrients limitation on phytoplankton growth and microcystins production in Spring Lake, USA.

Su X, Steinman AD, Oudsema M, Hassett M, Xie L.

Chemosphere. 2019 Nov;234:34-42. doi: 10.1016/j.chemosphere.2019.06.047. Epub 2019 Jun 6.

PMID:
31203039
3.

Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.

Hassett MJ, Banegas M, Uno H, Weng S, Cronin AM, O'Keeffe Rosetti M, Carroll NM, Hornbrook MC, Ritzwoller DP.

J Oncol Pract. 2019 Jul;15(7):e616-e627. doi: 10.1200/JOP.19.00004. Epub 2019 May 20.

PMID:
31107629
4.

Performance of Cancer Recurrence Algorithms After Coding Scheme Switch From International Classification of Diseases 9th Revision to International Classification of Diseases 10th Revision.

Carroll NM, Ritzwoller DP, Banegas MP, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ.

JCO Clin Cancer Inform. 2019 Mar;3:1-9. doi: 10.1200/CCI.18.00113.

5.

Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data.

Uno H, Ritzwoller DP, Cronin AM, Carroll NM, Hornbrook MC, Hassett MJ.

JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00163.

6.

What drives variation in spending for breast cancer patients within geographic regions?

Sinaiko AD, Chien AT, Hassett MJ, Kakani P, Rodin D, Meyers DJ, Fraile B, Rosenthal MB, Landrum MB.

Health Serv Res. 2019 Feb;54(1):97-105. doi: 10.1111/1475-6773.13068. Epub 2018 Oct 14.

PMID:
30318592
7.

Effectiveness of Best Management Practices to Reduce Phosphorus Loading to a Highly Eutrophic Lake.

Steinman AD, Hassett M, Oudsema M.

Int J Environ Res Public Health. 2018 Sep 25;15(10). pii: E2111. doi: 10.3390/ijerph15102111.

8.

Use of Patient-Reported Outcome Measures in Quality Oncology Practice Initiative-Registered Practices: Results of a National Survey.

Zhang B, Lloyd W, Jahanzeb M, Hassett MJ.

J Oncol Pract. 2018 Oct;14(10):e602-e611. doi: 10.1200/JOP.18.00088. Epub 2018 Sep 12.

PMID:
30207853
9.

How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated?

Horiguchi M, Hassett MJ, Uno H.

Oncologist. 2019 Jul;24(7):867-871. doi: 10.1634/theoncologist.2018-0141. Epub 2018 Sep 10. No abstract available.

PMID:
30201741
10.

Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States.

Lin NU, Bichkoff H, Hassett MJ.

J Oncol Pract. 2018 Sep;14(9):525-528. doi: 10.1200/JOP.18.00428. Epub 2018 Aug 20. No abstract available.

PMID:
30125129
11.

Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis.

Ritzwoller DP, Fishman PA, Banegas MP, Carroll NM, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ.

Health Serv Res. 2018 Dec;53(6):5106-5128. doi: 10.1111/1475-6773.13014. Epub 2018 Jul 24.

PMID:
30043542
12.

Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer.

Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller DP.

JNCI Cancer Spectr. 2018 Apr;2(2):pky024. doi: 10.1093/jncics/pky024. Epub 2018 Jun 28.

13.

Estrogen-receptor status and risk of contralateral breast cancer following DCIS.

Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS.

Breast Cancer Res Treat. 2018 Oct;171(3):777-781. doi: 10.1007/s10549-018-4860-5. Epub 2018 Jun 26.

PMID:
29946862
14.

PIK-ing New Malaria Chemotherapy.

Hassett MR, Roepe PD.

Trends Parasitol. 2018 Nov;34(11):925-927. doi: 10.1016/j.pt.2018.06.003. Epub 2018 Jun 19. Review.

PMID:
29934102
15.

Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.

Ritzwoller DP, Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Kushi LC.

J Natl Cancer Inst. 2018 Mar 1;110(3):273-281. doi: 10.1093/jnci/djx200.

16.

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH.

J Clin Oncol. 2018 Aug 10;36(23):2433-2443. doi: 10.1200/JCO.2018.78.8604. Epub 2018 May 22.

PMID:
29787356
17.

Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ.

Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS.

J Natl Compr Canc Netw. 2018 Apr;16(4):387-394. doi: 10.6004/jnccn.2018.7003.

PMID:
29632058
18.

Chemotherapy medication errors.

Weingart SN, Zhang L, Sweeney M, Hassett M.

Lancet Oncol. 2018 Apr;19(4):e191-e199. doi: 10.1016/S1470-2045(18)30094-9. Review.

PMID:
29611527
19.

Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.

Uno H, Hassett MJ, Wei LJ.

JAMA. 2018 Jan 16;319(3):306. doi: 10.1001/jama.2017.18312. No abstract available.

PMID:
29340668
20.

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.

Poorvu PD, Vaz-Luis I, Freedman RA, Lin NU, Barry WT, Winer EP, Hassett MJ.

Breast Cancer Res Treat. 2018 Apr;168(3):727-737. doi: 10.1007/s10549-018-4659-4. Epub 2018 Jan 13.

PMID:
29332137
21.

Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.

Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D.

Med Care. 2017 Dec;55(12):e88-e98. doi: 10.1097/MLR.0000000000000404.

22.

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA.

Breast Cancer Res Treat. 2018 Feb;167(3):751-759. doi: 10.1007/s10549-017-4553-5. Epub 2017 Oct 28.

PMID:
29079937
23.

Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms.

Hassett MR, Riegel BE, Callaghan PS, Roepe PD.

Biochemistry. 2017 Oct 17;56(41):5615-5622. doi: 10.1021/acs.biochem.7b00749. Epub 2017 Sep 26.

PMID:
28898049
24.

Usability Considerations in Oncology Electronic Medical Records.

Hassett MJ.

J Oncol Pract. 2017 Aug;13(8):539-541. doi: 10.1200/JOP.2017.024745. No abstract available.

PMID:
28796970
25.

Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.

Chen CT, Li L, Brooks G, Hassett M, Schrag D.

Health Serv Res. 2018 Aug;53(4):2118-2132. doi: 10.1111/1475-6773.12745. Epub 2017 Jul 26.

26.

Quality Improvement in the Era of Big Data.

Hassett MJ.

J Clin Oncol. 2017 Oct 1;35(28):3178-3180. doi: 10.1200/JCO.2017.74.1181. Epub 2017 Jul 24. No abstract available.

PMID:
28737974
27.

Heterologous Expression, Purification, and Functional Analysis of Plasmodium falciparum Phosphatidylinositol 3'-Kinase.

Hassett MR, Sternberg AR, Riegel BE, Thomas CJ, Roepe PD.

Biochemistry. 2017 Aug 22;56(33):4335-4345. doi: 10.1021/acs.biochem.7b00416. Epub 2017 Aug 8.

PMID:
28719180
28.

Inhibition of Human Class I vs Class III Phosphatidylinositol 3'-Kinases.

Hassett MR, Sternberg AR, Roepe PD.

Biochemistry. 2017 Aug 22;56(33):4326-4334. doi: 10.1021/acs.biochem.7b00413. Epub 2017 Aug 8.

PMID:
28719179
29.

Survival after recurrence of stage I-III breast, colorectal, or lung cancer.

Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Fishman P, Ritzwoller DP.

Cancer Epidemiol. 2017 Aug;49:186-194. doi: 10.1016/j.canep.2017.07.001. Epub 2017 Jul 12.

30.

Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology.

Gabryszewski SJ, Dhingra SK, Combrinck JM, Lewis IA, Callaghan PS, Hassett MR, Siriwardana A, Henrich PP, Lee AH, Gnädig NF, Musset L, Llinás M, Egan TJ, Roepe PD, Fidock DA.

PLoS Pathog. 2016 Nov 10;12(11):e1005976. doi: 10.1371/journal.ppat.1005976. eCollection 2016 Nov.

31.

Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update.

Ganz PA, Hassett MJ, Miller DC.

Am Soc Clin Oncol Educ Book. 2016;35:e294-300. doi: 10.14694/EDBK_159303.

32.

Plasmodium falciparum chloroquine resistance transporter (PfCRT) isoforms PH1 and PH2 perturb vacuolar physiology.

Callaghan PS, Siriwardana A, Hassett MR, Roepe PD.

Malar J. 2016 Mar 31;15:186. doi: 10.1186/s12936-016-1238-1.

33.

Implementation of the 21-gene recurrence score test in the United States in 2011.

Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN.

Genet Med. 2016 Oct;18(10):982-90. doi: 10.1038/gim.2015.218. Epub 2016 Feb 11.

PMID:
26890451
34.

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.

Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU.

Breast Cancer Res Treat. 2016 Feb;155(3):569-78. doi: 10.1007/s10549-016-3707-1. Epub 2016 Feb 11.

PMID:
26868124
35.

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.

Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS.

Breast Cancer Res Treat. 2016 Feb;155(3):541-9. doi: 10.1007/s10549-016-3692-4. Epub 2016 Feb 3.

36.

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.

Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D.

Cancer. 2016 Feb 1;122(3):420-31. doi: 10.1002/cncr.29777. Epub 2015 Nov 4.

37.

Mushrooms as Rainmakers: How Spores Act as Nuclei for Raindrops.

Hassett MO, Fischer MW, Money NP.

PLoS One. 2015 Oct 28;10(10):e0140407. doi: 10.1371/journal.pone.0140407. eCollection 2015.

38.

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):622-30. doi: 10.1016/j.ijrobp.2015.07.006. Epub 2015 Jul 11.

PMID:
26461004
39.

Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).

Callaghan PS, Hassett MR, Roepe PD.

Biochemistry. 2015 Aug 18;54(32):5083-94. doi: 10.1021/acs.biochem.5b00412. Epub 2015 Aug 6.

40.

Short-range splash discharge of peridioles in Nidularia.

Hassett MO, Fischer MW, Money NP.

Fungal Biol. 2015 Jun;119(6):471-5. doi: 10.1016/j.funbio.2015.01.003. Epub 2015 Jan 29.

41.

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.

Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU.

Cancer. 2015 Jun 15;121(12):1937-48. doi: 10.1002/cncr.29310. Epub 2015 Mar 10.

42.

Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.

Brooks GA, Li L, Uno H, Hassett MJ, Landon BE, Schrag D.

Health Aff (Millwood). 2014 Oct;33(10):1793-800. doi: 10.1377/hlthaff.2014.0280.

43.

The relationship between quality, spending and outcomes among women with breast cancer.

Hassett MJ, Neville BA, Weeks JC.

J Natl Cancer Inst. 2014 Sep 13;106(10). pii: dju242. doi: 10.1093/jnci/dju242. Print 2014 Oct.

PMID:
25217776
44.

High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit.

Hassett MJ, McNiff KK, Dicker AP, Gilligan T, Hendricks CB, Lennes I, Murray T, Krzyzanowska MK.

J Oncol Pract. 2014 May;10(3):e160-6. doi: 10.1200/JOP.2013.001240. Epub 2014 Feb 18.

PMID:
24549319
45.

Splash and grab: biomechanics of peridiole ejection and function of the funicular cord in bird's nest fungi.

Hassett MO, Fischer MW, Sugawara ZT, Stolze-Rybczynski J, Money NP.

Fungal Biol. 2013 Oct;117(10):708-14. doi: 10.1016/j.funbio.2013.07.008. Epub 2013 Aug 14.

46.

Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab.

Shin J, Liang SY, Hassett MJ, Phillips KA, Haas JS.

Per Med. 2013 Sep;10(7):703-708. doi: 10.2217/pme.13.68.

PMID:
29768759
47.

What does breast cancer treatment cost and what is it worth?

Hassett MJ, Elkin EB.

Hematol Oncol Clin North Am. 2013 Aug;27(4):829-41, ix. doi: 10.1016/j.hoc.2013.05.011. Review.

PMID:
23915747
48.

Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?

Weingart SN, Zhu J, Young-Hong J, Vermilya HB, Hassett M.

J Oncol Pharm Pract. 2014 Jun;20(3):163-71. doi: 10.1177/1078155213487395. Epub 2013 Jun 26.

PMID:
23804625
49.

Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.

Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS.

J Natl Cancer Inst. 2013 Jun 5;105(11):774-81. doi: 10.1093/jnci/djt096. Epub 2013 May 3.

50.

Improving electronic oral chemotherapy prescription: can we build a safer system?

Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M.

J Oncol Pract. 2012 Nov;8(6):e168-73. doi: 10.1200/JOP.2012.000677. Epub 2012 Sep 25.

Supplemental Content

Loading ...
Support Center